Our vision is to be the most trusted Sudanese pharmaceutical manufacturing company providing the highest international standards quality products and health care services for human as well as animal by applying innovative technologies and ideas so as to exceed our customer expectation and strive to achieve their satisfaction.
step
Our Vision:
Our mission:
To maintain the continuity of the improvement and development of health services in humans and animals with production of high quality medicines and reasonable prices
Our Values:
Our core values define what we stand for, how we conduct ourselves and how we interact with colleagues, customers, vendors, shareholders and others.
- Our priority is to pay more attention for human and animal health care.
- In all our activities we are committed to the highest level of ethical and professional standards.
- We give special recognition to our employees and act to develop their knowledge, skills and work behavior so that they can innovate and meet the challenges confidently and without fear.
- We aim to create an open institutional culture and a modern, effective and active management that respects privacy, individual ability and team work.
- We respect and seek to engage a wide range of clients, ideas and business partners in our daily practices and activities.
- We promote a safe, functional, and supportive environment within the organization so that quality and safety are preserved.
- Our culture is based on empowerment of employees through a spirit of cooperation, respect, participation and speed of achievement.
- Mutual trust and credibility are the keys on which we challenge ourselves to thrive from success to success.
> Protection of the environme
Bash Pharma adopts the best technologies that provide environmental hygienic conditions inside and outside the project.
> Bash Pharma Pharmaceuticals company at glance: or
> Milestones
2012 establishment of bash pharma
2014, may first product in the market
2014, September production of veterinary liquids preparation.
2015, December release of veterinary injectable products to the market.
2018, January new leadership took over the management.
2018, June launch of bash pharma human eye drops.
Our Slogan:
“We care for health to care for life”.
Plant at Glance:
Location:-
Sobba Industrial zone, square 11, block No. 8
Land total area:-
24990 m²
Labors & Employees:-
216 permanents + casual labor
The Factory units:
First: The main building (4800 m²)
The Factory units:
First: The main building (4800 m²)
The building consists of:-
A/ Production area:-
The production area is about (1200m²)
Composed of glass reinforced plastic (GRP) partitions which are resistant to fire, humidity, bacterial & fungal growth and dust. It is specially designed for pharmaceutical Industry. in addition to that, the plant has a special epoxy coated floor.
B/ Production lines:-
The production lines is
Composed of 5 main lines including veterinary
As well as human products lines.
1/ Veterinary lines:-
Consist of powders, liquids, bolus and injectable lines (it is
The first injectable line in Sudan)
2/Human Medicines line:-
This line produces all types of drops (eye, ear, nasal), it
C/ Plant capacity:-
The plant capacity for 8 working hours/day for the different
production lines are as shown in the following lable:-
-
Production line Unit size Designed capacity Expected capacity 1/ liquids 1lit. ½ lit.
4,320,000
5,040,000
2,592,000
3,600.000
2/Powder 1 kg. ½kg
1,152,000
1,440,000
864,000
1,224,000
3/ Injectable 100ml 50ml
3,600,000
4,320,000
2,880,000
3,660,000
4/ Drops 5ml 10ml
7,200,000
5,040,000
5,760,000
4,320,000
Second: Laboratories:
The total area 500 m² and cosists of:
1/ Microbiological lab.
2/ Wet chemistry lab.
3/ Instruments lab.
4/ R & D lab.
The equipments are imported from Germany, Norway, Japan, India, and others.
All buildings of labs are furnished with sealing roof, aluminum partitions, epoxy floor, and cladding.
Third: Different facilities and other buildings :
Total area 11,350 m² and includes:-
1/ Raw materials stores.
2/Final production stores.
3/Preliminary packaging material store.
4/Secondary packaging material store.
5/Plastic bottles factory.
6/ Water treatment units.
7/Compressors.
8/ Fire Extinguishing System.
9/Electricity generators.
10/ Air treatment Unit.
11/Lavatories.
12/Boilers .
13/ Administration& services offices.
14/ Internal Roads.
15/ Fuel tanks.
16/Water supply (wells &tanks).
17/ Gardens.
18/ Fences & Interlock.
Date of Veterinary medicines Production:
Official production started with powder & liquid products on at 22/4/2014
Date of Human Medicines Production:
All construction and commissioning activities have been completed and human medicines official commercial production expected to be started by the beginning of year 2015 after completing of the stability studies.
Invested Capital:
The invested capital is about $ US 25,000,000 including the raw materials cost.
Bashpharma Products:
1-Injectables:
Dosage Form
|
Generic Name
|
Trade Name
|
No
|
Injection |
Oxytetracycline 5% |
OXYLIN 5% |
1 |
Injection |
Oxytetracycline 20% |
OXYLIN 20% |
2 |
Injection |
Ivermectin 1% |
AVOMECTIN |
3 |
Injection |
Diminazine Aceturate |
TRYPAZINE |
4 |
Injection |
Tylosin 20% |
TYLOFARM |
5 |
Injection |
Enrofoxacin 10% |
ENROXIN |
6 |
Injection |
Rafoxanide+Ivermectin |
RAFOMECTIN |
7 |
Injection |
Sulphadimidine Sodium33% |
SULFAZINE |
8 |
Injection |
AD3E |
VIT-AD3E |
9 |
Inj. |
Florfenicol 30% |
Floricol 30% |
10 |
2- Liquids:
Dosage Form
|
Generic Name
|
Trade Name
|
No
|
solution |
Ivermectin 0.08% Drench |
AVOMECTIN |
1 |
Suspension |
Albendazole 2.5% |
ALBENAMED |
2 |
Suspension |
Levamisole 30%+Oxyclozanide 60% |
LEVANIDE |
3 |
Suspension |
Levamisole 15%+Oxyclozanide 30% |
LEVANIDE – DS |
4 |
solution |
Amproium |
SUPERAMPROL |
5 |
solution |
Tetramisole 5% |
TETRAPAM |
6 |
3-Powders:
Dosage Form
|
Generic Name
|
Trade Name
|
No
|
Powder |
Tetramisole 10% |
TETRAPAM 10 |
1 |
Powder |
Tetramisole 30% |
TETRAPAM 30 |
2 |
Powder |
Tetramisole 10% |
Pamisole(Underlicence) |
3 |
4- Human Drops:
Dosage form
|
Generic Name
|
No
|
solution |
Gatifloxacin0.3% ophthalmic |
1 |
solution |
Ketorolac 0.4% ophthalmic |
2 |
solution |
Moxifloxacin 0.5% & Dexamethasone 0.1% ophthalmic |
3 |
solution |
Moxifloxacin 0.5% ophthalmic |
4 |
solution |
Olopatadine Hcl 0.1% ophthalmic |
5 |
solution |
Tobramycin 0.3% ophthalmic |
6 |
solution |
Travoprost 0.004% ophthalmic |
7 |
solution |
Gatifloxacin +Dexamethasone |
8 |
solution |
Tobramycim + Dexamethasone |
9 |
5- Items in pipeline:
Dosage Form
|
Generic Name
|
Trade Name
|
No
|
Inj. |
Buperviquone 5% |
Buperviquone |
1 |
liquid |
Triclabendazol 10% |
Triclabendazol |
2 |
Inj. |
Oxytetracycline Hcl 20%+ diclofinac sod |
Oxylin LA plus |
3 |
Inj. |
Oxytetracycline Hcl 30% |
Oxylin Extra |
4 |
liquid |
Oxytetracycline Hcl 30%+flunixim |
Oxylin Extra plus |
5 |
Powder |
Tylosin |
Tylofarm Liquid |
6 |
liquid |
Triclabendazol 10%+ivermectin |
Triclabendazol + ivermectin |
7 |
Powder |
Vitamins+ minirals amino acids |
Subli – Veet or Co- Diet |
8 |
Powder |
Albendazole .5% |
Albenamed powder. 5% |
9 |
solution |
Flubendazole solu .2.5% |
Flubendal solu |
10 |
- Use Tooltips
- Use Icons
- CPU
- Memory
-
$19
- 256 MB Memory
-
49$
- 512 MB Memory
-
109$
- 1000 MB Memory